News
By Lynn Song Trade balance beat forecasts as export growth accelerated while import growth slowed Export growth unexpectedly accelerated to a 17-month high China’s...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
News
This article was written by Follow Equity strategist + Co-PM Global Equities [Bernard Holdings]. Objective view on the directional bias of markets. Technical expertise...
News
This article was written by Follow I am a value focused investor. Stocks rise and fall for many different reasons that we often cannot...
News
This article was written by Follow My analysis is focused on high-quality companies, that can outperform the market over the long-run due to a...
News
The last month hasn’t been much fun for investors. The concentration has been based upon the elections, the wars in Ukraine and Israel, and...
News
Listen to the well-known journalists James Mackintosh from the Wall Street Journal: “We have entered a new market paradigm with a focus on economic...
News
The Kayne Anderson Energy Infrastructure Fund (NYSE:KYN) is a closed-end fund that invests primarily in midstream corporations and master limited partnerships. This is an...
News
A Hold Rating for Shares of AngloGold Ashanti plc This analysis reiterates the Hold rating for shares of AngloGold Ashanti plc (NYSE:AU), a Greenwood,...
News
This is a follow-up analysis of our prior report, “Nasdaq 100: Bears may still be lurking around the corner” published on 15 August 2024....
News
Oil prices have struggled on Tuesday morning as US markets return from the Labor Day holiday. Brent is trading 3% down at the time...
News
Introduction Per my May article, Brookfield Corporation (NYSE:BN) allocates capital shrewdly. Since then, a July 17 Bloomberg article discussed management changes. The 2Q24 letter...
News
AT&T Inc. (NYSE:T) has never gotten credit for the new cash flow pattern now that management has ditched all the noncore businesses. The last...
News
Deals and Financings Belgium’s UCB (OTCPK:UCBJF, OTCPK:UCBJY) announced plans to divest its entire current China five-drug portfolio, narrowing its China focus to commercialize soon-to-arrive...
